White Papers

Targeting Regional Growth Opportunities for Medical Devices Companies

Posted January 17, 2017| Tarun Mehra
Investment by both corporate and equity investors continues to grow in emerging markets in search of growth opportunities. As one might expect, formulating such growth strategy and evaluating new targets of investment, require new skills and knowledge; they also introduce new risks.

Our experience with clients has pinpointed three very common strategic errors that executives make, or risks they face, while pursuing growth opportunities in high-growth regions such as Latin America, Asia, and Africa: Homogeneity Risk, Analogous Market Risk, and Absolute Attractiveness Risk.

To understand these risks better, Fuld + Company took a closer look at a consulting engagement we had with a medical devices firm. A case study will demonstrate the seductive power of these three risks and the behavior exhibited by our client executives to realize their errors and refine their investment strategy.

Download the Whitepaper:

  • This field is for validation purposes and should be left unchanged.

Tags: , , , , ,

Related Resources

Read More

Early Warning Toolkit

Establish an early warning system that keeps your company one step ahead of market trends + competitors. Early warning programs empower […]

Read More

Planning for the Unpredictable, The Future of Healthcare: The Shifting Burden of Risk

Given the uncertainty surrounding the healthcare industry, stakeholders struggle to develop business strategies that can guide both near- and long-term […]

Read More

A Mixed Blessing For the Commercial Aircraft Industry – New Entrants

The global fleet of commercial aircraft consists overwhelmingly of machines built by a handful of manufacturers in Western Europe, North […]

z

Subscribe to our mailing list for our latest updates: